Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States).

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMID 12708728)

Published in Cancer Causes Control on February 01, 2003

Authors

M L Slattery1, Rachel Ballard-Barbash, Sandra Edwards, Bette J Caan, John D Potter

Author Affiliations

1: Health Research Center, Department of Family and Preventive Medicine, 375 Chipeta Way, Suite A, University of Utah, Salt Lake City, UT 84108, USA.

Articles citing this

Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56

Influence of obesity on the risk of developing colon cancer. Gut (2005) 1.93

Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol (2007) 1.73

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2008) 1.42

Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res (Phila) (2009) 1.32

Association between body size and colorectal adenoma recurrence. Clin Gastroenterol Hepatol (2007) 1.28

Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause (2009) 1.27

Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control (2012) 1.26

Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26

Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.24

Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol (2009) 1.21

Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev (2006) 1.20

Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst (2012) 1.19

Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis (2010) 1.19

An association between obesity and the prevalence of colonic adenoma according to age and gender. J Gastroenterol (2007) 1.08

Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer (2008) 1.04

Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer (2006) 1.01

Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit (2013) 0.92

Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study. PLoS One (2014) 0.92

Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev (2009) 0.92

Variation in the CYP19A1 gene and risk of colon and rectal cancer. Cancer Causes Control (2011) 0.89

Associations between obesity and changes in adult BMI over time and colon cancer risk. Obesity (Silver Spring) (2008) 0.87

Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Dis Colon Rectum (2012) 0.86

Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. Br J Cancer (2007) 0.86

Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality. PLoS One (2013) 0.85

The Association between Polymorphismsin Insulin and Obesity Related Genesand Risk of Colorectal Cancer. Iran J Cancer Prev (2013) 0.82

Oral contraceptive use and colorectal cancer in the Nurses' Health Study I and II. Cancer Epidemiol Biomarkers Prev (2015) 0.82

Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer. World J Gastroenterol (2014) 0.81

A prospective study of oral contraceptive use and colorectal adenomas. Cancer Causes Control (2016) 0.81

Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. Cancer Causes Control (2012) 0.80

Obesity and colorectal cancer. Clin Colon Rectal Surg (2011) 0.80

Changing population characteristics, effect-measure modification, and cancer risk factor identification. Epidemiol Perspect Innov (2007) 0.80

Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol (2016) 0.79

Is there an estrogenic component in the metabolic syndrome? Genes Nutr (2006) 0.77

Increasing incidence of colon cancer in patients <50 years old: a new entity? Ann Transl Med (2016) 0.77

Role of RUNX2 in Breast Carcinogenesis. Int J Mol Sci (2015) 0.76

The association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women. Dig Dis Sci (2010) 0.75

Adult BMI Change and Risk of Colon Cancer in Postmenopausal Women. J Obes (2012) 0.75

Impact of Increased Visceral Fat Measured by CT on Colon Adenocarcinoma Stage. J Gastrointest Cancer (2016) 0.75

Articles by these authors

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17

Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol (2003) 8.25

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol (2002) 8.03

Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73

Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol (2003) 7.68

Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst (2008) 6.79

Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28

Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA (2007) 6.02

Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev (2007) 6.00

Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17

Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 5.04

Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53

Performance benchmarks for screening mammography. Radiology (2006) 4.41

Antibiotic use in relation to the risk of breast cancer. JAMA (2004) 4.28

Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev (2005) 4.11

VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol (2004) 3.97

Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75

Improving gene set analysis of microarray data by SAM-GS. BMC Bioinformatics (2007) 3.68

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58

Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55

A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials (2002) 3.41

Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology (2008) 3.35

Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25

Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA (2003) 3.22

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer (2006) 3.19

Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst (2006) 3.08

Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst (2013) 2.99

Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88

Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol (2013) 2.87

Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85

Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85

Identification of Lynch syndrome among patients with colorectal cancer. JAMA (2012) 2.77

Physical activity recommendations and decreased risk of mortality. Arch Intern Med (2007) 2.76

Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75

Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA (2008) 2.73

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics (2003) 2.69

Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res (2009) 2.59

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56

Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54

Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med (2006) 2.53

Insights into colon cancer etiology via a regularized approach to gene set analysis of GWAS data. Am J Hum Genet (2010) 2.50

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst (2003) 2.48

High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst (2013) 2.46

Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol (2010) 2.44

Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst (2002) 2.42

Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat (2007) 2.41

Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology (2007) 2.39

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38

Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol (2003) 2.38

Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology (2002) 2.36

Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35

Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol (2010) 2.31

Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst (2003) 2.29

Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26

Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr (2006) 2.25

Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med (2007) 2.23

Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol (2002) 2.19

Comparative evaluation of gene-set analysis methods. BMC Bioinformatics (2007) 2.19

Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology (2008) 2.14

Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev (2013) 2.14

Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14

Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev (2008) 2.12

Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet (2002) 2.08

Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev (2002) 2.08

It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park) (2013) 2.07

Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA (2004) 2.07

Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol (2003) 2.06

Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer (2010) 2.05

Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04

Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res (2007) 2.02

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02

Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol (2005) 2.01

Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol (2010) 2.00

Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst (2010) 1.99

Screening for colorectal cancer and prostate cancer: challenges for New Zealand. N Z Med J (2014) 1.97

Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause (2004) 1.97

Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst (2013) 1.96

Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet (2008) 1.96

Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev (2009) 1.95

Estimating kinship in admixed populations. Am J Hum Genet (2012) 1.95

Characteristics of childhood cancer survivors predicted their successful tracing. J Clin Epidemiol (2004) 1.94

Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.94

Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer (2006) 1.92

Buccal cell DNA yield, quality, and collection costs: comparison of methods for large-scale studies. Cancer Epidemiol Biomarkers Prev (2002) 1.92

A national framework for cancer surveillance in the United States. Cancer Causes Control (2005) 1.89

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int (2008) 1.88

Folate and cancer--timing is everything. JAMA (2007) 1.88

Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol (2015) 1.87

Self-reported and objectively measured activity related to biomarkers using NHANES. Med Sci Sports Exerc (2011) 1.87

A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum (2009) 1.85

Personalized exposure assessment: promising approaches for human environmental health research. Environ Health Perspect (2005) 1.83

Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83